IMRE

Cloud Cybersecurity & Infrastructure Resilience · vs · Identity Verification & Fraud Defense

Imprivata vs Realeyes

Structured technology and market comparison · 2026

Direct Feature Comparison

Imprivata · vs · Realeyes
Direct Feature Comparison: Imprivata vs Realeyes
Attribute
IMImprivata
RERealeyes
Market Cluster / SectorCloud Cybersecurity & Infrastructure ResilienceIdentity Verification & Fraud Defense
Business Model / RoleB2B SaaS ProviderB2B SaaS Provider
Platform FocusHealthcare-focused identity and access management software provider.Vision AI software for authentication and human data licensing.
Company SizeUnknown50–200 employees
HeadquartersUnited StatesEstonia
Year FoundedUnknown2007
Dossier & Alternatives

Analyze all overlapping signals and tech stacks for Imprivata and Realeyes

Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.

Compare in PlatformInstant access · 1-click via Google/LinkedIn

Comparison Analysis

What is the main difference between Imprivata and Realeyes?

When comparing Imprivata and Realeyes, both platforms operate within the Identity Provider (IdP) & SSO and B2B SaaS Provider ecosystem. Imprivata is positioned as Healthcare-focused identity and access management software provider, whereas Realeyes focuses on Vision AI software for authentication and human data licensing. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.

What are the top alternatives to Imprivata and Realeyes?

When evaluating Imprivata and Realeyes, enterprise buyers also consider other platforms in Identity Provider (IdP) & SSO and B2B SaaS Provider. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

How do the corporate scale, structure, and headquarters of Imprivata and Realeyes compare?

Imprivata is headquartered in United States (founding year unrecorded) with Unknown. Realeyes is based in Estonia (founded in 2007) with 50–200 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.

Market Signals

Recent Market Signals & Activity: Imprivata vs Realeyes

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

IM

Imprivata

Recent Signals

  • ·ImprivataProduct & Platform Launch

    Imprivata Recognized for the First Time in the Gartner® Magic Quadrant™ for Privileged Access Management

    Imprivata announced its inaugural inclusion in the Gartner Magic Quadrant for Privileged Access Management published on October 21, 2026. The company unites enterprise privileged access management, vendor privileged access management (VPAM), and agentic AI access security into a unified platform. Gartner highlighted Imprivata's market responsiveness, pricing, and product capabilities as primary strengths.

    • Imprivata was recognized for the first time in the Gartner Magic Quadrant for Privileged Access Management, published on October 21, 2026.
    • The evaluation cited Imprivata's market responsiveness, pricing, and product capabilities as core strengths.
    • Imprivata's Privileged Access Security platform combines enterprise PAM, Vendor Privileged Access Management (VPAM), and Customer Privileged Access Management (CPAM).
  • ·ImprivataProduct & Platform Launch

    Authentication Issues Cost Frontline Organizations Thousands of Working Hours Each Year According to Research from Imprivata and FIDO Alliance

    A research report by Imprivata and the FIDO Alliance reveals that authentication difficulties among frontline workers delay patient care, production, and deliveries across mission-critical industries. Surveying 700 IT and security decision-makers across the US, UK, France, and Germany, the study found that average organizations lose roughly 32,400 working hours annually to authentication friction. Furthermore, widespread workarounds and the emergence of AI-enabled employee impersonation are driving calls for full passwordless passkey adoption.

    • The survey was conducted by Sapio Research in August 2026 among 700 IT and security decision-makers in the US, UK, France, and Germany.
    • Authentication issues cause an average organization with 2,800 frontline workers to lose approximately 32,400 working hours per year.
    • 34% of respondents (and 40% in healthcare) report that authentication problems delay patient care, production, or delivery.
  • ·ImprivataProduct & Platform Launch

    Imprivata and Verosint merge branding, websites and other marketing materials in support of the recent Imprivata acquisition of Verosint

    Imprivata has completed the transition and consolidation of all applicable Verosint marketing assets and web content into imprivata.com following its recent acquisition of Verosint. The unified web presence provides a centralized location for Verosint's Identity Threat Detection and Response (ITDR) capabilities alongside Imprivata's access management suite. Existing Verosint customers will experience no changes in how they contact the company for support or inquiries.

    • Imprivata finalized the migration of Verosint's website, content, and marketing materials into www.imprivata.com on October 14, 2026.
    • The integration consolidates Verosint's Identity Threat Detection and Response (ITDR) platform into the broader Imprivata access management portfolio.
    • Existing Verosint customers will retain their existing support and inquiry contact channels without changes.
RE

Realeyes

Recent Signals

No recent market signals documented for Realeyes in the current tracking window.

Compare their exact ecosystem overlaps.

Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Imprivata and Realeyes share across the market ecosystem.